Chronic myelogenous leukemia: Laboratory diagnosis and monitoring

Y. Lynn Wang, A. Bagg, Warren Pear, Peter C. Nowell, Jay L. Hess

Research output: Contribution to journalReview article

46 Scopus citations

Abstract

Rapid developments have occurred both in laboratory medicine and in therapeutic interventions for the management of patients with chronic myelogenous leukemia (CML). With a wide array of laboratory tests available, selecting the appropriate test for a specific diagnostic or therapeutic setting has become increasingly difficult. In this review, we first discuss, from the point of view of laboratory medicine, the advantages and disadvantages of several commonly used laboratory assays, including cytogenetics, fluorescence in situ hybridization (FISH), and qualitative and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). We then discuss, from the point of view of clinical care, the test(s) of choice for the most common clinical scenarios, including diagnosis and monitoring of the therapeutic response and minimal residual disease in patients treated with different therapies. The purpose of this review is to help clinicians and laboratory physicians select appropriate tests for the diagnosis and monitoring of CML, with the ultimate goal of improving the cost effective usage of clinical laboratories and improving patient care.

Original languageEnglish (US)
Pages (from-to)97-111
Number of pages15
JournalGenes Chromosomes and Cancer
Volume32
Issue number2
DOIs
StatePublished - Sep 26 2001
Externally publishedYes

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Chronic myelogenous leukemia: Laboratory diagnosis and monitoring'. Together they form a unique fingerprint.

  • Cite this